Found: 6
Select item for more details and to access through your institution.
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.
- Published in:
- Kidney International, 2011, v. 79, n. 11, p. 1236, doi. 10.1038/ki.2011.33
- By:
- Publication type:
- Article
A Review of Oral Transmucosal Fentanyl Citrate: Potent, Rapid and Noninvasive Opioid Analgesia.
- Published in:
- Journal of Palliative Medicine, 1998, v. 1, n. 1, p. 55, doi. 10.1089/jpm.1998.1.55
- By:
- Publication type:
- Article
M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 4, p. 1031, doi. 10.1002/cpt.1276
- By:
- Publication type:
- Article
Oral Transmucosal Fentanyl Citrate Premedication in Patients Undergoing Outpatient Dermatologic Procedures.
- Published in:
- Journal of Dermatologic Surgery & Oncology, 1994, v. 20, n. 12, p. 823, doi. 10.1111/j.1524-4725.1994.tb03712.x
- By:
- Publication type:
- Article
Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Oral transmucosal fentanyl citrate for premedication in paediatric outpatients.
- Published in:
- 1990
- By:
- Publication type:
- journal article